Showing results (211-220 of 279) with videos related to

Sort By:
Pageof 28
Journal of Oral Rehabilitation|March 7, 2008
National survey on edentulism and its geographic distribution, among Mexicans 18 years of age and older (with emphasis in WHO age groups)C E Medina-Solís, R Pérez-Núñez, G Maupomé, et al.
Revista Alergia Mexico (Tecamachalco, Puebla, Mexico : 1993)|January 5, 2002
[Desensitization to human recombinant DNA insulin in an adolescent with insulin-dependent diabetes mellitus]M A Rosas Vargas, M Alvarez Amador, L M Alvarez Amador, et al.
Revista Do Instituto De Medicina Tropical De Sao Paulo|March 1, 1994
Evaluation of different methods for Plasmodia detection, in well defined population groups in an endemic area of Brazil (1)S L Avila, M C Leandro, N B Carvalho, et al.
Journal of Anxiety Disorders|November 1, 2015
Treatment of active duty military with PTSD in primary care: A follow-up reportJeffrey A Cigrang, Sheila A M Rauch, Jim Mintz, et al.
Acta Otorrinolaringologica Espanola|November 24, 2004
[Malignant neck paraganglioma with a rare localization]M J Padilla Romero, J M Amador García, F Santiago Moreno, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 26, 2018
The current prevalence of asthma, allergic rhinitis, and eczema related symptoms in school-aged children in Costa RicaM E Soto-Martínez, A Yock-Corrales, K Camacho-Badilla, et al.
Transplantation|July 6, 2016
Unique CD8+ T Cell-Mediated Immune Responses Primed in the LiverJason M Zimmerer, Phillip H Horne, Mason G Fisher, et al.
Journal of Substance Use and Addiction Treatment|June 9, 2024
Observations of substance use treatment engagement during the period of community re-entry following residential treatmentNoam G Newberger, Diana Ho, Emmanuel D Thomas, et al.
Thrombosis Research|July 10, 2016
Pediatric post-thrombotic syndrome in children: Toward the development of a new diagnostic and evaluative measurement toolM L Avila, L R Brandão, S Williams, et al.
Drugs - Real World Outcomes|May 29, 2025
Real-World Treatment Outcomes in Black, Hispanic, Asian, and White Patients with Multiple Sclerosis Treated with NatalizumabKaren Blitz-Shabbir, Aimee M Banks, Hina Garg, et al.
Pageof 28